65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79726D0210
- Awardee
-
Genzyme Corporation UEI X2XMAQLR9DA8
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment Pre-Solicitation · M5Q50A03R8 · Posted Jun 21, 2018
- Last date to order 1% complete
- IDV ceiling
- $670,000,000.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
The Veterans Integrated Service Network 12 (VA) issued a Federal Supply Schedule contract to Genzyme Corporation under GSA Schedule 65 I B (Drugs, Pharmaceuticals, & Hematology Related Products) on September 29, 2026, with a $670 million ceiling through September 30, 2031. This is a multiple-award schedule vehicle through which VA medical centers and VISNs nationwide issue delivery orders for specialty pharmaceutical products including Eliglustat (Cerdelga), Lemtrada, Caprelsa (vandetanib), and cancer therapeutics. Genzyme Corporation, doing business as Sanofi Genzyme, serves as prime contractor with no set-aside designation. Delivery orders issued under this schedule have ranged from emergency procurements to larger bulk medication purchases, with performance periods spanning weeks to over one year. Deliveries are made to VA medical facilities across the country from places of performance including Cambridge, Massachusetts and Riverwoods, Illinois. The schedule offers a catalog-based ordering mechanism allowing multiple VA Networks to access Genzyme's pharmaceutical portfolio without running separate competitions, streamlining the procurement of specialty medications to support veteran healthcare programs.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36F79726D0210?
36F79726D0210 was awarded to Genzyme Corporation by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 29, 2026.
How much is contract 36F79726D0210 worth?
36F79726D0210's own ceiling is $670,000,000.
Who can order from contract 36F79726D0210?
36F79726D0210 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79726D0210 part of a contract vehicle?
Yes. 36F79726D0210 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79726D0210 competed?
The extent of competition for 36F79726D0210 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV